Abstract

Aim In this study we evaluated the concordance between vFXM and aFXM using SAB and a predetermined cut off point that has been established in our laboratory. Methods AXM: 773 crossmatches performed by FCXM were retrospectively analyzed. The cut off for T &B are 64, 100 respectively. This includes 573 crossmatches performed using PB/ or spleen deceased donor cells with potential recipients & 200 consecutive final crossmatches performed for living transplantation. VXM: Donor HLA- antigens were compared against the potential recipient’s antibody specificities. Prediction of vFXM was based on antibody identification using SAB. Normalized MFI values of 3000 were used to identify antibodies predicted to cause a positive FCXM for A, B, DR &5000 for HLA-C and DQ specificities when present as single antibody. A sum of multiple weak antibodies (MFI ⩽ 2000) that yield MFI of ⩾3000 was used to predict positivity. Results Only positive FCXM positive for B or B & T simultaneously are considered. The vast majority of aFXM were in concordance with vFXM with an overall concordance of 97%. Twenty-three predicted to be negative showed positive aFXM, 12 of them had 0% cPRA and 11 were found in patients with multiple non DSA- HLA- antibodies, dilution of these sera revealed weak DSA. Three predicted positive vFXM yield negative aFXM, two of them had allele specific antibodies. (Table 1). Because sera of highly sensitized patients are diluted we rarely deceived by prozone phenomenon. Therefore the only cause of false negative VXM is auto or non HLA- antibodies. Due to the extreme sensitivity of SAB, reporting false positive VXM remains a possibility and will continue to be a limitation for VXM. Conclusions vFXM based on precise characterization of antibody specificities detected by SAB using our cutoff point accurately predicted FXM in the majority of patients and can be used safely to allocate kidney offers without performing physical crossmatches in selected patients. Download : Download high-res image (61KB) Download : Download full-size image

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.